Pfizer Focused on Delivering the Value Customers Expect and Shareholders Deserve, CEO Kindler Tells Shareholders
"We've accomplished a lot already. But it's clear we need to do much more to get to where we want to be. All of our efforts are focused on achieving our ultimate goal - making significant improvements in the company's performance and generating greater total returns for you, our shareholders.
"While it's clear we're operating in a very competitive business environment today, I also believe that we have a very wide and attractive set of opportunities to drive our success in the years ahead and enhance returns to our shareholders.
"We are focused on driving revenue growth, executing better, controlling costs, instilling greater accountability across the company and making sure we deliver the value our customers expect and our shareholders deserve."
In other business, 12 of the company's directors stood for and were re-elected to one-year terms. In other voting, shareholders ratified the selection of KPMG as Pfizer's independent auditor for 2007. No shareholder resolutions received a majority vote.
Bryant Haskins, 212-733-8719
Posted: April 2007